Form D — Ansa Biotechnologies, Inc.
0001231919-26-001596 · filed Nov 18, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $71,903,290
- Reported amount sold
- $54,403,290
- Minimum investment
- $0
- Investors
- 18
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Ansa Biotechnologies, Inc.
- CIK
- 1816722
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1198 65TH STREET #250
EMERYVILLE, California 94608 - Phone
- 9256908100
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jason T Gammack · Executive OfficerEmeryville, California Find on LinkedIn ↗
-
Daniel Lin-Arlow · Executive OfficerEmeryville, California Find on LinkedIn ↗
-
Yanniv Dorone · DirectorEmeryville, California Find on LinkedIn ↗
-
Brad Crutchfield · DirectorEmeryville, California Find on LinkedIn ↗
-
Nate Cornell · DirectorEmeryville, California Find on LinkedIn ↗
-
Nick Naclerio · DirectorEmeryville, California Find on LinkedIn ↗
-
Chenny Zhang · DirectorEmeryville, California Find on LinkedIn ↗
-
Matthias Arenskotter · Executive OfficerEmeryville, California Find on LinkedIn ↗
-
Geoff Hamilton · Executive OfficerEmeryville, California Find on LinkedIn ↗
-
Sebastian Palluk · Executive OfficerEmeryville, California Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗